Literature DB >> 19672243

Adult mice generated from induced pluripotent stem cells.

Michael J Boland1, Jennifer L Hazen, Kristopher L Nazor, Alberto R Rodriguez, Wesley Gifford, Greg Martin, Sergey Kupriyanov, Kristin K Baldwin.   

Abstract

Recent landmark experiments have shown that transient overexpression of a small number of transcription factors can reprogram differentiated cells into induced pluripotent stem (iPS) cells that resemble embryonic stem (ES) cells. These iPS cells hold great promise for medicine because they have the potential to generate patient-specific cell types for cell replacement therapy and produce in vitro models of disease, without requiring embryonic tissues or oocytes. Although current iPS cell lines resemble ES cells, they have not passed the most stringent test of pluripotency by generating full-term or adult mice in tetraploid complementation assays, raising questions as to whether they are sufficiently potent to generate all of the cell types in an organism. Whether this difference between iPS and ES cells reflects intrinsic limitations of direct reprogramming is not known. Here we report fertile adult mice derived entirely from iPS cells that we generated by inducible genetic reprogramming of mouse embryonic fibroblasts. Producing adult mice derived entirely from a reprogrammed fibroblast shows that all features of a differentiated cell can be restored to an embryonic level of pluripotency without exposure to unknown ooplasmic factors. Comparing these fully pluripotent iPS cell lines to less developmentally potent lines may reveal molecular markers of different pluripotent states. Furthermore, mice derived entirely from iPS cells will provide a new resource to assess the functional and genomic stability of cells and tissues derived from iPS cells, which is important to validate their utility in cell replacement therapy and research applications.

Entities:  

Mesh:

Year:  2009        PMID: 19672243     DOI: 10.1038/nature08310

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  30 in total

1.  Dissecting direct reprogramming through integrative genomic analysis.

Authors:  Tarjei S Mikkelsen; Jacob Hanna; Xiaolan Zhang; Manching Ku; Marius Wernig; Patrick Schorderet; Bradley E Bernstein; Rudolf Jaenisch; Eric S Lander; Alexander Meissner
Journal:  Nature       Date:  2008-05-28       Impact factor: 49.962

2.  Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution.

Authors:  Nimet Maherali; Rupa Sridharan; Wei Xie; Jochen Utikal; Sarah Eminli; Katrin Arnold; Matthias Stadtfeld; Robin Yachechko; Jason Tchieu; Rudolf Jaenisch; Kathrin Plath; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2007-06-07       Impact factor: 24.633

3.  Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision.

Authors:  A Novak; C Guo; W Yang; A Nagy; C G Lobe
Journal:  Genesis       Date:  2000 Nov-Dec       Impact factor: 2.487

4.  Fate of tetraploid cells in 4n<-->2n chimeric mouse blastocysts.

Authors:  Gillian E Mackay; John D West
Journal:  Mech Dev       Date:  2005-11-04       Impact factor: 1.882

5.  Induced pluripotent stem cells from a spinal muscular atrophy patient.

Authors:  Allison D Ebert; Junying Yu; Ferrill F Rose; Virginia B Mattis; Christian L Lorson; James A Thomson; Clive N Svendsen
Journal:  Nature       Date:  2008-12-21       Impact factor: 49.962

6.  Mice cloned from olfactory sensory neurons.

Authors:  Kevin Eggan; Kristin Baldwin; Michael Tackett; Joseph Osborne; Joseph Gogos; Andrew Chess; Richard Axel; Rudolf Jaenisch
Journal:  Nature       Date:  2004-02-15       Impact factor: 49.962

7.  Generation of human-induced pluripotent stem cells.

Authors:  In-Hyun Park; Paul H Lerou; Rui Zhao; Hongguang Huo; George Q Daley
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

8.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.

Authors:  Marius Wernig; Alexander Meissner; Ruth Foreman; Tobias Brambrink; Manching Ku; Konrad Hochedlinger; Bradley E Bernstein; Rudolf Jaenisch
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

9.  Derivation of completely cell culture-derived mice from early-passage embryonic stem cells.

Authors:  A Nagy; J Rossant; R Nagy; W Abramow-Newerly; J C Roder
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

10.  Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds.

Authors:  Danwei Huangfu; René Maehr; Wenjun Guo; Astrid Eijkelenboom; Melinda Snitow; Alice E Chen; Douglas A Melton
Journal:  Nat Biotechnol       Date:  2008-06-22       Impact factor: 54.908

View more
  160 in total

Review 1.  Induced pluripotent stem cells--opportunities for disease modelling and drug discovery.

Authors:  Marica Grskovic; Ashkan Javaherian; Berta Strulovici; George Q Daley
Journal:  Nat Rev Drug Discov       Date:  2011-11-11       Impact factor: 84.694

2.  Induced Pluripotent Stem Cells-A New Foundation in Medicine.

Authors:  George T-J Huang
Journal:  J Exp Clin Med       Date:  2010-10-22

3.  Molecular insights into the heterogeneity of telomere reprogramming in induced pluripotent stem cells.

Authors:  Fang Wang; Yu Yin; Xiaoying Ye; Kai Liu; Haiying Zhu; Lingling Wang; Maria Chiourea; Maja Okuka; Guangzhen Ji; Jiameng Dan; Bingfeng Zuo; Minshu Li; Qian Zhang; Na Liu; Lingyi Chen; Xinghua Pan; Sarantis Gagos; David L Keefe; Lin Liu
Journal:  Cell Res       Date:  2011-12-20       Impact factor: 25.617

4.  Nkx2.2 repressor complex regulates islet β-cell specification and prevents β-to-α-cell reprogramming.

Authors:  James B Papizan; Ruth A Singer; Shuen-Ing Tschen; Sangeeta Dhawan; Jessica M Friel; Susan B Hipkens; Mark A Magnuson; Anil Bhushan; Lori Sussel
Journal:  Genes Dev       Date:  2011-11-01       Impact factor: 11.361

5.  Induced pluripotent stem cell-derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in mice.

Authors:  Silvia Espejel; Garrett R Roll; K John McLaughlin; Andrew Y Lee; Jenny Y Zhang; Diana J Laird; Keisuke Okita; Shinya Yamanaka; Holger Willenbring
Journal:  J Clin Invest       Date:  2010-08-25       Impact factor: 14.808

6.  Production of mice using iPS cells and tetraploid complementation.

Authors:  Xiao-Yang Zhao; Zhuo Lv; Wei Li; Fanyi Zeng; Qi Zhou
Journal:  Nat Protoc       Date:  2010-04-29       Impact factor: 13.491

7.  Induced pluripotent stem cells: paths to new medicines. A catalyst for disease modelling, drug discovery and regenerative therapy.

Authors:  Wenbin Deng
Journal:  EMBO Rep       Date:  2010-02-19       Impact factor: 8.807

8.  Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency.

Authors:  Bao-Yang Hu; Jason P Weick; Junying Yu; Li-Xiang Ma; Xiao-Qing Zhang; James A Thomson; Su-Chun Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-16       Impact factor: 11.205

Review 9.  Viable fertile mice generated from fully pluripotent iPS cells derived from adult somatic cells.

Authors:  Xiao-yang Zhao; Wei Li; Zhuo Lv; Lei Liu; Man Tong; Tang Hai; Jie Hao; Xiang Wang; Liu Wang; Fanyi Zeng; Qi Zhou
Journal:  Stem Cell Rev Rep       Date:  2010-09       Impact factor: 5.739

Review 10.  Embryonic and induced pluripotent stem cells as a model for liver disease.

Authors:  Hiroshi Yagi; Edgar Tafaleng; Masaki Nagaya; Marc C Hansel; Stephen C Strom; Ira J Fox; Alejandro Soto-Gutierrez
Journal:  Crit Rev Biomed Eng       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.